| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $592K | +51.4% |
| Cost of Revenue | $198K | +9.4% |
| R&D Expense | $5.6M | +5.1% |
| SG&A Expense | $7.6M | -17.9% |
| Operating Income | -$17.9M | +0.4% |
| Interest Expense | $1.3M | +193.8% |
| Net Income | -$18.6M | +2.3% |
| EPS (Diluted) | -$5.74 | -963.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.0M | -37.8% |
| Accounts Receivable | $59K | -45.9% |
| Inventory | $999K | +101.4% |
| Current Assets | $15.4M | -35.9% |
| Total Assets | $17.6M | -32.4% |
| Current Liabilities | $4.8M | +65.4% |
| Long-term Debt | $4.6M | -42.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.5M | -21.1% |
| Capital Expenditures | $224K | -52.3% |
| Investing Cash Flow | -$224K | +52.3% |
| Financing Cash Flow | $9.2M | -44.9% |
| Free Cash Flow | -$17.7M | -18.8% |
| Total Liabilities |
| $14.7M |
| -10.7% |
| Stockholders' Equity | $3.0M | -69.2% |